High Pressure Homogenisation & the next generation of drug delivery: Liposomes
24 February 2016 | By Biopharma Group
Liposomes are valued delivery vehicles for potent and efficacious active pharmaceuticals...
List view / Grid view
24 February 2016 | By Biopharma Group
Liposomes are valued delivery vehicles for potent and efficacious active pharmaceuticals...
2 February 2016 | By GlobalData
A GlobalData analyst says increased collaboration and further financial incentives are required to fight the mounting threat posed by superbugs...
29 January 2016 | By Victoria White
Allergan and AstraZeneca are to develop and commercialise ATM-AVI, an investigational, fixed-dose antibiotic combining aztreonam and avibactam...
Mega mergers, 3D printed drugs, a call for action on antimicrobial resistance: 2015 certainly was an interesting year for the pharmaceutical industry. Here we pick a selection of the top stories that hit the headlines.
21 January 2016 | By Victoria White
More than 80 companies and organisations have signed the Declaration on Combating Antimicrobial Resistance (AMR), an industry-wide call to action...
Hollow Fibre Diafiltration is rapid alternative to traditional methods of nanoparticle purification like ultracentrifugation.
We describe a no-wash, high throughput screen that provides a multiparametric activity profile for a structure activity relationship (SAR) library derived from immunomodulatory compounds...
14 January 2016 | By DiscoveRx
DiscoveRx Corporation announced the expansion of its PathHunter cell-based assays portfolio with the release of PathHunter Checkpoint Assays...
11 January 2016 | By Victoria White
Cancer vaccine SCIB1 is a DNA ImmunoBody immunotherapy encoding a human IgG1 antibody, with three epitopes from gp100 and one from TRP-2 engineered into its CDR regions...
In digital version of Issue #6 2015: Microbiology, Screening, PCR, Continuous Manufacturing, PAT, Regulation, and much more...
6 January 2016 | By Irmgard Riedmaier, Melanie Spornraft, Benedikt Kirchner and Michael W. Pfaffl, Technical University of Munich
Molecular diagnostics and biomarker discovery are gaining increasing attraction in clinical research. This includes all fields of diagnostics, such as risk assessment, disease prognosis, treatment prediction and drug application success control. The detection of molecular clinical biomarkers is very widespread and can be developed on various molecular levels, like the…
4 January 2016 | By Victoria White
University of Illinois researchers have found that a number of existing drugs approved for the treatment of various conditions, such as cancer or infertility, show promise as antibiotic agents...
7 December 2015 | By Victoria White
Breakpoints of new agents are absolutely vital in standardising a global definition of resistance and the point at which increased dosages are needed...
18 November 2015 | By Victoria White
Survey results released by the ECDC show that the situation continues to worsen with regard to the spread of CPE in the EU, with 3 countries reporting an endemic situation...
13 November 2015 | By Victoria White
Ahead of the European Antibiotic Awareness Day, ESCMID has highlighted two of its more recent projects in the fight against antimicrobial resistance...